ILU

1.65%

$6.57 iluka resources limited

I believe there will be around 530 million shares on issue as...

First 2 Last

Share
Profile

Follow
sb2231

27 Posts.

1

20/10/20

11:06

Post #: 48228236
Share

Originally posted by muzdaz: ↑

Hi all,
I am a long term holder of ILU shares. From my reading we will now be receiving 1 Deterra Royalties (DRR) share for every ILU share held and these shares will be able to be traded on the ASX as of 3 November 2020.

Q1: The demerger paper issued by ILU says "Last time and date by which Sale Facility Forms must be received by Iluka Share Registry 2.00pm (AWST) Thursday, 22 October 2020" and "Last date Iluka Shares trade on ASX cum-entitlements under the Demerger is Thursday, 22 October 2020." If I bought ILU shares today (20/10/2020) on the ASX, triple checking that they would qualify as shares that would receive a 1 for 1 DRR share allocation?

Q2: There are currently 422.5 million ordinary ILU shares on issue which I assume will mean there will be 422.5 million DDR shares or have I missed something here?

Q3: The Royalties paid to ILU for 2019 after tax was 54.5 million. DRR plans on issuing 100% of each year after tax royalty payment (minus running costs) as dividends to holders. So if DRR was running as an ASX company in 2019, shareholders would have received a dividend of approximately 12 cents???

Q4: 2020 and onwards, (iron ore price dependant) looks as though area C will be expanding and doubling production, therefore creating greater dividends???

Q5: My biggest and dumbest question of the lot, any ideas what will happen to the ILU share price when DRR lists??? Has the market already factored the demerger in yet???

Thank you all in advance. As you can see, I am just a mum and dad investor and not an expert. It just seems strange that no one is talking about the DRR proposal, as all other royalty companies overseas appear to be kicking ass. Also it seems like a guaranteed dividend.

Expand

I believe there will be around 530 million shares on issue as ILU will take a 20% stake in DRR

The demerger will only be priced in after the ex date to receive the 1 DRR share for every ILU share

\

ILU Price at posting: $9.75 Sentiment: None Disclosure: Not Held
4 Upvote

0 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

There are more pages in this discussion • 60 more messages in this thread...

First 2 Last

Add ILU (ASX) to my watchlist

(20min delay)
Last $6.57		Change -0.110(1.65%)		Mkt cap ! $2.813B

Open	High	Low	Value	Volume
$6.55	$6.59	$6.41	$13.12M	2.009M

Buyers (Bids)

No.	Vol.	Price($)
1	1386	$6.55

Sellers (Offers)

Price($)	Vol.	No.
$6.57	9080	4

View Market Depth

No.	Vol.	Price($)
2	3588	6.420
2	8437	6.400
2	240	6.260
1	100	6.250
1	3221	6.210

Price($)	Vol.	No.
6.590	2850	1
6.600	188	1
6.650	3300	1
6.660	898	1
6.700	2006	2

Last trade - 16.10pm 04/10/2024 (20 minute delay)

ILU (ASX) Chart

I believe there will be around 530 million shares on issue as...

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I believe there will be around 530 million shares on issue as...

Top Stories

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News